Re Agreement

RNS Number:1735L
Celsis International PLC
16 May 2003


                           Celsis International plc

                       Agreement with Boots Manufacturing


Celsis International plc ("Celsis"), a world leading rapid microbial testing
company whose diagnostic systems detect and measure contamination for the
pharmaceutical, personal care, dairy and beverage industries, announces an
agreement to supply the Celsis AdvanceTM system to Boots Manufacturing (BM) to
increase their product screening capability.

Boots Manufacturing is one of the leading developers and manufacturers of
Healthcare and Toiletry Products in Europe.  Their dosage form expertise spans
solid dose and powders, liquids and creams and sterile products ranging from
injectables to ophthalmic preparations.

The Celsis AdvanceTM system provides BM with product screening test results in
as little as 24 hours, thus markedly enhancing BM's ability to detect potential
microbial quality problems as well as reduce "product for sale" release times
over other more traditional screening methods.  The net result to BM and other
Celsis customers is significant financial savings by more effectively managing
their supply chains to retail sale and reduced inventory and warehousing costs.


Jay LeCoque, Chief Executive Officer, Celsis commented:

"We are delighted that Boots Manufacturing has decided to implement the Celsis
AdvanceTM system in their UK manufacturing facility.  I know the importance of
Boots in the UK and in Europe and this agreement has been one of my personal
objectives since we re-developed our customer facing capabilities in Europe.  BM
is one of Europe's leading contract developers and manufacturers in the personal
care and over-the-counter pharmaceutical arenas and this investment will allow
them enhanced control over their supply chain and quality management systems."



                                                                     16 May 2003


Enquiries:

Celsis International plc                                       Tel: [phone]
Jay LeCoque, Chief Executive Officer
Jenny Parsons, Corporate Communications

College Hill                                                   Tel: [phone]
Nicholas Nelson





Notes to editors


Celsis International plc

Celsis International plc is a world leader in the development and supply of
rapid diagnostic and monitoring systems to detect and measure microbial
contamination in finished products bound for consumers.  It has successfully
developed tests for use in the pharmaceutical, cosmetic and toiletries, food and
beverage industries and is associated with some of the best-known high street
brands in these consumer areas.

These tests are based upon the years of research in enzyme technology that
employ numerous methods for the rapid detection of microbial contamination.  The
result is that microbial testing times are reduced from around five days to a
little over one day, thus lending significant cost advantages to Celsis'
customers.

Celsis International plc also has a leading cGMP laboratory services, supporting
the R&D and manufacturing based testing needs of the pharmaceutical,
biotechnology and personal care industries.  This business unit currently
operates primarily in the United States.

For more information on Celsis International plc go to www.celsis.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGRNKPKDOBKDBPD